Decentralized clinical trials for medications to reduce the risk of dementia: consensus report and guidance
INTRODUCTION: Recent growth in the functionality and use of technology has prompted an increased interest in the potential for remote or decentralized clinical trials in dementia. There are many potential benefits associated with decentralized medication trials, but we currently lack specific recomm...
- Autores:
-
Howard, Leanne
Abdelnour, Carla
Abner, Erin L.
Allegri, Ricardo F.
Dodge, Hiroko H.
Gauthier, Serge
Hoyos, Camilla M.
Jicha, Gregory A.
Kehoe, Patrick G.
Mummery, Catherine J.
Ogunniyi, Adesola
Scarmeas, Nikolaos
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2024
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/13666
- Acceso en línea:
- https://hdl.handle.net/11323/13666
https://repositorio.cuc.edu.co/
- Palabra clave:
- Decentralized clinical trials
Delphi process
Dementia prevention
Recommendations
Remote clinical trials
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)